Criterium, Inc.
Clinical trials sponsored by Criterium, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cocktail of three drugs targets Hard-to-Treat breast cancer Results expected Jun 2027 (estimated)